On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Market Closed -
Other stock markets
|
After market 07:59:42 pm | |||
40.49 USD | -1.82% | 40.52 | +0.07% |
May. 28 | Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License | MT |
May. 27 | Bristol Myers: will present data on schizophrenia | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.09% | 82.08B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.26% | 238B | |
+7.18% | 204B | |
-6.38% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company